The vaccinia virus (VV) strain
Introduction
Vaccinia virus (VV) is the prototype poxvirus and replicates in the cell cytoplasm (Moss, 1996) . VV strain Copenhagen has a 191 kb dsDNA genome encoding approximately 200 genes (Goebel et al., 1990) . Many of the genes located near the genomic termini affect virus host-range or virulence or help the virus to evade the host response to infection. For instance, VV encodes proteins that block the action of non-specific defences such as complement, interferon and cytokines (for reviews see Smith, 1994 ; McFadden, 1995) .
VV possesses several gene families one of which encodes three proteins related to serine protease inhibitors (serpins) (Boursnell et al., 1988 ; Kotwal & Moss, 1989 ; Smith et al., 1989) . Each of these are non-essential for virus replication but they have different functions (for review see Turner et al., Author for correspondence : Geoffrey L. Smith.
Fax j44 1865 275501. e-mail glsmith!molbiol.ox.ac.uk systemic effect mediated by IL-1β. Instead, fever is controlled by the VV IL-1β receptor, encoded by gene B15R, and deletion of both the B13R and B15R genes did not increase the febrile response compared to deletion of B15R alone. The B13R protein does, however, block apoptosis mediated by anti-Fas antibodies or by tumour necrosis factor (TNF) and cycloheximide. Using DNA fragmentation, chromium release and microscopic analyses it was shown that cells infected with wild-type VV strain WR, or a revertant virus in which the B13R gene had been re-inserted into the B13R deletion mutant, are more resistant than uninfected cells or deletion mutant-infected cells to apoptosis mediated by antiFas and TNF. 1995). The K2L gene product (SPI-3) prevents fusion of infected cells (Law & Smith, 1992 ; Zhou et al., 1992) . The B22R protein (SPI-1) of rabbitpox virus (RPV) (a VV strain) affects RPV host-range and RPV strains lacking this gene induce apoptosis in pig kidney (PK-15) cells or human lung carcinoma (A549) cells (Ali et al., 1994 ; Brooks et al., 1995) . However, this gene does not affect the virulence of RPV or VV strain Western Reserve (WR) in intranasally infected BALB\c mice (Thompson et al., 1993 ; Kettle et al., 1995) .
The third serpin gene, termed cytokine response modifier A (crmA) in cowpox virus (CPV) strain Brighton Red (BR), or B13R in VV WR (collectively called SPI-2), has been extensively studied. It is a stable, intracellular protein of 38 kDa that is synthesized early during infection (Pickup et al., 1986 ; Kettle et al., 1995) but is expressed by only the minority of the VV strains tested (Kettle et al., 1995) . CPV crmA induces the formation of haemorrhagic pocks on the chorioallantoic membrane (CAM) of the fertile hen's egg (Pickup et al., 1986) and also affects arachidonic acid metabolism (Palumbo et al., 1993) . Although crmA is a serpin it inhibits both the interleukin (IL)-1β-converting enzyme (ICE), a cysteine protease (Ray et al., 1992) , and granzyme B, a serine protease (Quan et al., 1995) . Inhibition of ICE by crmA prevents the production of mature IL-1β (Howard et al., 1995) , but CPV and most VV strains also express a soluble IL-1β receptor (vIL-1βR) (Alcamı! & Smith, 1992 ; Spriggs et al., 1992) which inhibits IL-1β-mediated fever in response to VV infection (Alcamı! & Smith, 1996) . A potentially more important role for crmA\B13R\SPI-2 is the prevention of programmed cell death (apoptosis) which ICE induces in response to several stimuli (Kumar, 1995 ; Patel et al., 1996) . For instance, crmA inhibits apoptosis in response to withdrawal of nerve growth factor from dorsal root ganglion neurones (Gagliardini et al., 1994) as well as Fas ligand-and tumour necrosis factor (TNF)-induced apoptosis in a variety of cell lines (Enari et al., 1995 ; Los et al., 1995 ; Miura et al., 1995 ; . CrmA also blocks the Ca# + -independent cytotoxic T lymphocyte (CTL)-killing pathway . Recently, infection with VV strain WR, but not strain Copenhagen which lacks the B13R protein, was shown to induce resistance of B lymphoblast and T lymphoblast cell lines to CD95 (Fas)-mediated apoptosis (Heinkelein et al., 1996) and the crmA protein prevents apoptosis of pig kidney LLC-PK " cells after CPV infection (Ray & Pickup, 1996) .
Since B13R shares 92 % amino acid identity with the crmA protein, it may have similar functions. However, differences in the roles of these proteins have been noted : while crmA was a potent inhibitor of inflammatory response during CPV infection of CAMs, VV B13R did not show any significant inhibition (Pickup et al., 1986 ; Palumbo et al., 1994) ; also, in a murine intranasal model, deletion of crmA caused virus attenuation, whereas deletion of vaccinia B13R did not (Thompson et al., 1993 ; Kettle et al., 1995) . In this paper we demonstrate that B13R inhibits ICE and thus prevents the production of mature IL-1β from pro-IL-1β. Despite this, it is the VV soluble vIL-1βR rather then B13R that controls the febrile response to infection in mice, which is mediated by IL-1β. Lastly, we demonstrate that during VV infection, B13R inhibits Fas-and TNF-α-induced apoptosis.
Methods
Cells and viruses. VV strain WR and CPV strain BR were used throughout. The VV WR B13R deletion mutant (∆B13R), a genetically close wild-type (wt) virus (B13RWT), a revertant virus in which the B13R locus of ∆B13R is restored to wt (B13Rrev) and a B15R deletion mutant (∆B15R) have previously been described (Alcamı! & Smith, 1992 ; Kettle et al., 1995) . A VV lacking both the B13R and B15R genes (∆B13R\ B15R) was obtained exactly as described for the isolation of the B13R deletion mutant (Kettle et al., 1995) except that the starting virus was ∆B15R (Alcamı! & Smith, 1992) rather than wt WR. In this procedure, during the resolution of the mycophenolic acid-resistant intermediate virus, a new B15R deletion mutant and ∆B13R\ B15R were isolated. The former virus was used in the experiments described in this paper since it is genetically closer to ∆B13R\B15R than is the original ∆B15R (Alcamı! & Smith, 1992) . All viruses were grown in BSC-1 cells in Dulbecco's modification of minimal essential medium (DMEM) with 2n5 % foetal bovine serum (FBS). Viruses were purified through a sucrose cushion and titrated by plaque assay as described (Mackett et al., 1985) . THP-1 cells were maintained in RPMI 1640 with 5 % FBS. HeLa spinner cells were maintained at 3-5i10& cells\ml in DMEM with 10 % FBS. Epstein-Barr virus-transformed B lymphoblasts (B-LCL) were maintained in RPMI 1640 with 15 % FBS.
In vitro ICE inhibition assay. This assay was similar to that previously described (Kostura et al., 1989) . Pro-IL-1β and IL-1β mRNAs were transcribed in vitro from plasmids pGEM-4Z or pGEM-3Z, respectively (Symons et al., 1995 b) , using the Riboprobe Gemini II system (Promega). mRNAs were then translated in vitro in the presence of 25 µCi in vivo labelling grade [$&S]methionine (Amersham) using micrococcal nuclease-treated rabbit reticulocyte lysates (Promega) to produce pro-IL-1β and IL-1β of 33 and 17 kDa, respectively. Approximately 4i10' THP-1 cells were infected with VV for 4 h. The cells were washed twice with Dulbecco's PBS lacking calcium and magnesium (Gibco BRL), resuspended in 30 µl 10 mM Tris-HCl pH 8n0 and freezethawed three times. Ten µl of cell lysate was incubated for 2 h at 37 mC with 1 µl of 1 : 10 diluted, radiolabelled pro-IL-1β and the proteins were resolved by SDS-PAGE on a 15 % gel and detected by fluorography.
Cell-based ICE inhibition assay. THP-1 cells (5i10&) were incubated for 24 h with 10 ng\ml phorbol myristate ester (PMA) (Sigma) and 100 ng\ml Escherichia coli serotype O55 : B5 lipopolysaccharide (LPS) (Sigma). This treatment induced pro-IL-1β expression (Fenton et al., 1988 ; Spriggs et al., 1990) . The PMA\LPS-stimulated THP-1 cells were infected with VV for 24 h. Supernatants from 3i10$ cells were clarified by centrifugation for 5 min in a microfuge and the proteins were resolved by SDS-PAGE and immunoblotted with polyclonal sheep anti-IL-1β serum followed by anti-sheep IgG horseradish peroxidase and detection by enhanced chemiluminescence (ECL) reagents (Amersham) as described by the manufacturer.
IL-1β soluble receptor binding assay. IL-1β soluble receptor binding assays were performed as previously described (Alcamı! & Smith, 1992 ; Symons et al., 1995 b) . Supernatants were incubated in duplicate with murine "#&I-IL-1β (80-180 µCi\µg, Dupont-New England Nuclear) in a final volume of 150 µl for 2 h at room temperature. "#&I-IL-1β-receptor complexes were precipitated with polyethylene glycol, collected by filtration onto Whatman GF\C filters and counted in a gamma counter. Background radioactivity precipitated in the presence of medium was subtracted.
Virulence and temperature measurement assays. Groups of five or ten, 5-to 6-week old, female BALB\c mice weighing between 15 and 20 g and housed at 20-22 mC were intranasally inoculated with VV in 25 µl of PBS. Aliquots of the virus dilutions were also titrated on BSC-1 cells to confirm the dose administered. Animals were weighed individually daily and those which had lost greater than 30 % of their original body weight were sacrificed by cervical dislocation. The rectal temperatures were measured as described (Alcamı! & Smith, 1996) . DAPI analysis. HeLa cells (5i10& cells) were grown in Lab Tek four-chamber slides (Nunc) for 48 h. Following infection for 8 h, the cells were washed with DMEM and treated with TNF-α, cycloheximide (CHX) or TNF\CHX. After 12-14 h at 37 mC, the cells were washed in PBS and treated for 10 min on ice with freshly prepared 4 % paraformaldehyde (PFA) in 250 mM HEPES pH 7n4. Cells were then incubated in 8 % PFA in 250 mM HEPES pH 7n4 for 20 min to 1 h at room temperature. The cells were finally washed once in PBS, mounted in mowiol containing DAPI and analysed using a Zeiss microscope (UV range) at a magnification of 63 by 1n5i. At least 300 cells were counted in each sample.
Chromium release assay. Standard chromium release assays were performed as described previously (Jassoy et al., 1992) . Briefly, cells were labelled with 80-100 µCi Na # &"CrO % for 60 min. For determination of anti-CD95 monoclonal antibody (MAb)-mediated lysis, 1i10% &"Crlabelled cells were incubated for an additional 5 h with 200 ng\ml of the anti-CD95 MAb CH-11 (Immunotech). After incubation, supernatants were harvested and counted in a gamma counter. Percent specific lysis was calculated by the formula : 100i(experimental releasekspontaneous release)\(maximum releasekspontaneous release). Maximum chromium release was determined by lysis of targets in 1n5 % Triton X-100. Spontaneous chromium release was less than 30 %.
Determination of intracellular DNA fragmentation. Cells (1n5-2i10') were incubated for 3n5 h with 200-400 ng\ml anti-CD95 MAb. Cells were pelleted, and then lysed for 10 min on ice in 10 mM Tris\EDTA containing 1 % Triton X-100. High molecular mass DNA in the supernatant was pelleted by ultracentrifugation and discarded. Low molecular mass DNA in the supernatant was obtained after phenol\ chloroform extraction and ethanol precipitation as described (McConkey et al., 1991) . DNA gel electrophoresis was performed using 1n8 % agarose gels in Tris-acetate\EDTA buffer.
Results
The B13R gene product inhibits ICE ICE converts the 31 kDa pro-IL-1β into active 17 kDa IL-1β and can also generate a 28 kDa fragment (Black et al., 1989 ; Kostura et al., 1989) . The human monocytic cell line THP-1 was used to investigate whether the B13R gene product can inhibit ICE. Lysates from infected THP-1 cells were incubated with in vitro synthesized and radiolabelled pro-IL-1β and the reaction products were visualized by SDS-PAGE and fluorography (Fig.  1 a) . Lysates from mock-infected or ∆B13R-infected THP-1 cells cleaved pro-IL-1β into a 17 kDa protein that co-migrated with IL-1β. However, IL-1β was not produced with lysates from cells infected with CPV, WR or B13Rrev [a revertant virus derived from ∆B13R by reinsertion of the B13R gene ( Kettle et al., 1995) ]. Therefore, the B13R protein, like crmA, inhibits ICE in vitro. This was confirmed by a more biologically relevant assay measuring the cleavage of pro-IL-1β and release from intact cells. THP-1 cells were treated with PMA and LPS to induce expression of pro-IL-1β and then infected for 24 h. The released pro-IL-1β and ICE-specific cleavage products (28 kDa protein and IL-1β) were detected in the supernatants by immunoblotting with anti-IL-1β serum (Fig. 1 b) . IL-1β was detected at low levels in the supernatants of WR-and B13Rrev-infected cells, but at higher levels in supernatants of ∆B13R-infected cells. CPV infection seemed to inhibit the cleavage of pro-IL-1β more efficiently than infection with VV WR.
Virulence of a B13R/B15R double deletion mutant
VV has two mechanisms to inhibit the production or function of IL-1β, namely the intracellular inhibition of ICE by the B13R protein and a soluble vIL-1βR (gene B15R) that sequesters IL-1β extracellularly. Deletion of the B15R gene resulted in increased loss of body weight, signs of illness and fever in intranasally infected mice (Alcamı! & Smith, 1992 , 1996 , whereas deletion of B13R did not alter virus virulence (Kettle et al., 1995) . We therefore investigated whether deletion of both B13R and B15R would alter virus virulence and induction of fever compared to loss of either B13R or B15R alone.
A B13R\B15R double deletion mutant (∆B13R\B15R) and a closely related B15R deletion mutant (∆B15R) were constructed (see Methods). The genomes of both viruses were carefully examined by Southern blotting and PCR and shown to be as predicted (data not shown). The expression of the B13R protein and the soluble vIL-1βR by these viruses was also examined. Immunoblot analysis using anti-B13R-2 serum (Kettle et al., 1995) confirmed that the B13R gene product was expressed by B13RWT and ∆B15R but not by ∆B13R or (Fig. 2 a) while the VV B5R protein (Engelstad et al., 1992) was expressed by all viruses (Fig. 2 b) . An assay for soluble vIL-1βR demonstrated that both B13RWT and ∆B13R expressed the vIL-1βR while ∆B15R and ∆B13R\B15R did not (Fig. 2 c) . Deletion of both B13R and B15R genes affected neither virus plaque size nor virus growth following low multiplicity of infection (data not shown). These data indicated that any effect noted in vivo was not due to a defect in virus replication.
The virulence of ∆B13R\B15R compared to WR, ∆B13R and ∆B15R was compared by measuring the mortality and weight loss of intranasally infected BALB\c mice (data not shown). With all viruses, infection at 10& or 10' p.f.u. caused a rapid and severe weight loss and all animals were sacrificed by day 6 post-infection. At 10% p.f.u. animals lost approximately 30 % of body weight and then recovered, but there was an accelerated weight loss in groups infected with ∆B15R and Fig. 3 . Body temperature and weight loss of mice infected with viruses lacking B13R, B15R or both genes. Groups of ten 5 to 6-week-old female, BALB/c mice were intranasally inoculated with 3i10 3 p.f.u. of either WR (#), ∆B13R (=), ∆B13R/B15R (>) or ∆B15R ($) viruses. The rectal temperature and weight of each mouse were measured daily before and after infection. The mean temperature of each mouse over 6 days prior to infection was calculated. Every day, the change in temperature relative to this mean was determined for each mouse and the mean of the group of ten mice was then calculated. Every day, the weight of each mouse was expressed as the proportion of its weight on day 0 and the mean of each group of ten was calculated. The mean basal temperature determined during 6 days before infection, which ranged from 35n7 to 35n8 mC (---), and the mean weight immediately prior to infection (---) are indicated. The horizontal bar indicates those days on which the difference between ∆B15R or ∆B13R/B15R and both WR or ∆B13R was statistically significant when analysed by Student's t-test, and the mean and maximum (in parentheses) P values are shown.
∆B13R\B15R compared to WR and ∆B13R (Student's t-test, P 0n05 on days 6 and 7). There were no significant differences in the number of mortalities. Therefore, deleting both the B13R and B15R genes did not alter virus virulence in terms of mortality, compared to deleting either B13R or B15R, or the accelerated weight loss compared to deleting B15R alone.
The accelerated weight loss of ∆B15R compared to WT had been noted previously (Alcamı! & Smith, 1992) and correlated with fever in these animals from days 2-6 post-infection (Alcamı! & Smith, 1996) . Since the B13R protein might reduce IL-1β levels due to its inhibition of ICE, the effect of deleting both B13R and B15R genes on the febrile response was compared to deleting B15R alone (Fig. 3) . Weight loss was also ) were then incubated with or without 400 ng/ml of the anti-CD95 MAb CH-11 for 3n5 h and low molecular mass DNA was prepared and separated by agarose gel electrophoresis. Lane M, 100 bp marker. (b) Inhibition of anti-CD95-mediated cytolysis by the VV B13R gene product. B-lymphoblasts (line 010-035i) were either mock-infected or infected as in (a) for 16 h. Cells were then labelled with 51 Cr and incubated for 5 h with 200 ng/ml anti-CD95 MAb CH-11. 51 Cr released into the supernatant was measured and the percentage specific lysis calculated (see Methods). The experiment was performed three times with duplicate samples and the mean values of these experiments (pSEM) are represented. The difference between mock or ∆B13R and both B13RWT measured (Fig. 3) . Infection with ∆B15R or ∆B13R\B15R produced a febrile response during days 4-6 that was statistically significant compared with WR (Fig. 3) . However, ∆B13R induced no fever showing that deletion of the B13R gene only was not sufficient to produce such a response. Notably, the duration and temperature of the ∆B15R-and ∆B13R\B15R-infected animals were comparable. Hypothermia was induced by all viruses after day 6 which correlates with virus dissemination and replication in the brain (Alcamı! & Smith, 1996) . All animals recovered from infection and body temperature returned to normal levels by 15 days postinfection (data not shown). Consistent with the results described in the previous paragraph (dose 10% p.f.u.), there was an accelerated weight loss with ∆B15R and ∆B13R\B15R compared to WR and ∆B13R which was statistically significant (Fig. 3) .
Overall, deleting both B13R and B15R genes did not alter the febrile response compared to deleting B15R alone. These data show that, although the B13R gene product inhibits ICE and hence the production of IL-1β from infected cells, the B15R protein is the predominant factor controlling the systemic effects of IL-1β in vivo, presumably because it can inhibit all available IL-1β whether it derives from infected or uninfected cells.
Apoptosis
The CPV crmA protein inhibits apoptosis in response to several stimuli (see Introduction) and, therefore, we investigated whether the related B13R protein from VV had a similar effect. In contrast to most studies with crmA we chose to investigate apoptosis in the context of virus infection using the WT, ∆B13R and B13Rrev viruses. Specifically, the ability of B13R to inhibit cell death induced by treatment with TNF or the anti-CD95 MAb CH-11 was examined.
Inhibition of Fas-mediated cell death by the B13R gene
product. Fas-mediated cell death was analysed by DNA fragmentation and chromium release assays. The detection of intracellular DNA fragments is one of the hallmarks of apoptosis. Fig. 4 (a) shows DNA laddering in the B-LCL cells treated with anti-CD95 antibody following mock infection or infection with ∆B13R. Laddering was not observed without addition of antibody or in cells treated with the antibody following infection with B13RWT or the B13Rrev viruses. Evidently, VV WR induces resistance to Fas-mediated apoptosis in B-LCL cells through the B13R protein.
Cell death was also measured by release of intracellular chromium as an indicator of cytolysis (Fig. 4 b) . Treatment of mock-or ∆B13R-infected cells with anti-CD95 MAb induced rapid death of the cells. In contrast, the cytotoxic activity of the and B13Rrev was statistically significant when analysed by Student's ttest (P 0n006).
DB13R

B13Rrev
Untreated TNF (500 U/ml) CHX (30 µg/ml) TNF+CHX (50 U/ml) Fig. 5 . Inhibition of TNF-α-mediated apoptosis by B13R. HeLa cells were mock infected or infected at 5 p.f.u. per cell with B13R WT, ∆B13R or B13Rrev for 8 h. After incubation with or without TNF and/or CHX, as indicated, for 12-14 h, the cell nuclei were stained with DAPI and examined using a fluorescence microscope. The cells were examined for changes in nuclear morphology following either no treatment (a-d) or treatment with 500 U/ml TNF (e-h), 30 µg/ml CHX (i-l) or 50 U/ml TNF and 30 µg/ml CHX (m-p). MAb was suppressed by infection with wt WR and the B13Rrev viruses. These result are consistent with the DNA fragmentation observed in Fig. 4 (a) .
Inhibition of TNF-mediated cell death by the B13R protein.
In contrast to normal cells, apoptotic cells have highly condensed chromatin which can be observed by fluorescent microscopy. Therefore, TNF-mediated cell death was analysed by comparing the nuclear morphology of DAPI-stained HeLa cells which had been treated with TNF (50 U\ml) and CHX (30 µg\ml) following mock infection or infection with different viruses (Figs 5 and 6 ). The nuclei of untreated and TNF-treated cells, which are mock infected or infected with either of the three viruses are intact and uniformly stained (Fig. 5 a-h) . Following CHX treatment, only mock-infected cells exhibit featureless chromatin in the form of spherical beads (Fig. 5 i) . Upon treatment with TNF and CHX both mock-infected and ∆B13R-infected cells show apoptotic morphology (Fig. 5 m, o) while most of the cells infected with B13RWT and B13Rrev viruses show intact nuclei (Fig. 5 n, p) . To obtain more quantitative data, 300 cells from each group were scored for apoptosis (Fig. 6 ). Most mock-infected cells (78 %) and ∆B13R-infected cells (68 %) were apoptotic, whereas only 22 % of B13RWT-infected or 17 % of B13Rrev-infected cells showed apoptosis. This indicates that the B13R gene product inhibits TNF\CHX-mediated apoptosis. At lower concentrations of TNF (5 U\ml) similar data were obtained although the proportion of ∆B13R-infected cells that was apoptotic was slightly lower (52 %). Treatment with CHX alone induced apoptosis in uninfected cells (66 %) but interestingly very few cells infected with any of the VVs were apoptotic (13-25 %). This demonstrates that in addition to B13R another VVencoded protein(s) which is present in the infecting virus particle is inhibiting CHX-mediated apoptosis. Lastly, in cells treated with TNF alone or in untreated cells there was very little or no apoptosis.
Discussion
Previously, it was established that the B13R gene product is a stable, intracellular 38n5 kDa protein that is synthesized early during infection. The protein is non-essential for virus replication in cell culture and its deletion does not alter virus virulence in a murine intranasal model. In this report we demonstrate that the B13R protein, like the closely related crmA protein of CPV, inhibits ICE. Despite this, loss of B13R did not affect the febrile response to infection, a systemic response induced by IL-1β. Instead, the VV soluble vIL-1βR, encoded by gene B15R, controlled fever. The B13R protein did, however, induce resistance of infected cells to apoptosis in response to anti-Fas antibodies or TNF and CHX.
The inhibition of ICE by VV B13R was shown by the inability of extracts from VV-infected THP-1 cells to cleave pro-IL-1β in vitro, whereas extracts from cells infected with VV lacking the B13R gene processed pro-IL-1β normally. This result was confirmed by measuring the cleavage of pro-IL-1β to IL-1β within intact cells infected with WT or ∆B13R viruses. The inhibition of ICE activity might have two or more effects. First, it would restrict the maturation and release of IL-1β from all infected cells and thereby reduce local or systemic IL-1β levels in the host. Second, it might affect apoptotic processes that involve ICE. Either of these might affect the host response to virus infection.
Considering a possible reduction in IL-1β, it was apparent that loss of the B13R protein played no major role in the outcome of infection in the murine intranasal model (Kettle et al., 1995) . Thus if the levels of IL-1β were reduced locally or systemically, the differences were not manifested in an altered response to infection. In contrast, the loss of the soluble vIL-1βR produced a more severe infection in this model as measured by weight loss, signs of illness and fever (Alcamı! & Smith, 1992 , 1996 . These effects were due to only IL-1β since the vIL-1βR was specific for IL-1β and not other cytokines (Alcamı! & Smith, 1992 , 1995 b, 1996 and administration of a MAb that neutralized IL-1β reversed the effects induced by deletion of the vIL-1βR (Alcamı! & Smith, 1996) . The febrile response to infection with ∆B13R was therefore measured and compared to infection with WT, ∆B15R and a virus lacking both B13R and the vIL-1βR. Loss of B13R alone neither altered weight loss nor induced a febrile response. Moreover, deletion of both B13R and the vIL-1βR did not produce a greater fever or weight loss than deletion of vIL-1βR alone, indicating that IL-1β produced by infected cells makes, at most, only minor changes to the systemic level of IL-1β. This result is consistent with the fact that VV strain Copenhagen, which is negative for B13R and vIL-1βR (Goebel et al., 1990 ; Alcamı! & Smith, 1992 ; Kettle et al., 1995) , induces a febrile response and this can be prevented by insertion of a functional vIL-1βR (Alcamı! & Smith, 1996) . Thus the vIL-1βR is dominant and is the principal method by which the virus controls the systemic levels of IL-1β. This is logical since a soluble vIL-1βR would bind and inhibit IL-1β whether it derives from infected cells or from uninfected cells recruited to the site of infection. In contrast, B13R would only block IL-1β production within infected cells and new synthesis of pro-IL-1β from these cells would in any case be inhibited by the virus-induced general inhibition of host protein synthesis.
Turning now to the inhibition of ICE related to apoptosis. Like the immune system, apoptosis is an important mechanism for limiting virus infection (Sellins & Cohen, 1989) , so it is not surprising that viruses encode proteins to counteract apoptosis (for review see Gillet & Brun, 1996) . CPV crmA is one such protein that has been well characterized and shown to inhibit IL-1β production in vitro (Ray et al., 1992) and protect against TNF-and Fas-induced apoptosis upon overexpression in various cell lines (Enari et al., 1995 ; Los et al., 1995 ; . However, the role of crmA and the VV B13R protein in inhibiting apoptosis during virus infection has not been shown until very recently (Dobbelstein & Shenk, 1996 ; Ray & Pickup, 1996) . Here, VV B13R is shown to inhibit ICE and TNF-and Fas-mediated apoptosis following viral infection. Moreover, since a B13R deletion mutant is sensitive to these processes and a revertant virus resistant, B13R is the only VV protein that mediates this inhibition. Although B13R protects against apoptosis mediated by TNF\CHX and Fas it does not prevent apoptosis induced by treatment with CHX alone. CHX was found to induce apoptosis in uninfected HeLa cells but not in HeLa cells infected with WT, deletion mutant or revertant virus (Fig. 6) . Thus another component of the infecting virus particle must prevent apoptosis under these latter conditions.
Although the B13R protein inhibits apoptosis in cell culture and this would be expected to be of an advantage during virus infection in vivo, the virulence of VV strains expressing the B13R protein was not enhanced in vivo (Kettle et al., 1995) . However, the degree of apoptosis in virus-infected cells was not examined in vivo and might be different despite there being no overall difference in virulence. Alternatively, the failure to observe a difference might reflect the model used and with CPV, for instance, the loss of crmA does affect the pock phenotype on the CAM (Pickup et al., 1986) .
In summary, we have demonstrated that the VV B13R protein inhibits ICE and apoptosis mediated by ICE-dependent pathways. B13R therefore represents another member of the growing group of virus proteins that inhibit apoptosis. Although the inhibition of ICE would reduce the production of IL-1β from infected cells, in vivo B13R did not alter fever, a systemic response mediated by IL-1β. Instead, it is the soluble vIL-1βR, encoded by gene B15R, that affects systemic IL-1β levels and inhibits fever.
